author-photo

Harold J. Wanebo

Roger Williams Medical Center
Landmark Medical Center

168

Papers

5806

Citations

Citation Trend

Filter By

Papers (168) Sort By

Journal Conference Others

Abstract 4294: C6 Ceramide potentiates paclitaxel and gemcitabine mediated antitumor effects against pancreatic cancer via inhibition of prosurvival PI3k/AKT/mTOR and ERK pathways

2019 Cancer Research
- Harold J. Wanebo
Show All
- Source
- Cite
- Save
Citations (0)
Predictive biomarkers in a phase II trial of weekly carboplatin (CBDCA), paclitaxel (P), and cetuximab (C) induction and chemoradiation (CRT) in patients (pts) with resectable stage III/IVa,b head and neck squamous cell carcinoma (HNSCC): Eastern Cooperative Oncology Group E2303.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Predictors for response to cetuximab in a prospective clinical trial (E2303) of patients with head and neck squamous cell carcinoma (HNSCC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Neoadjuvant pelvic perfusion may facilitate resection of pelvic recurrent rectal cancer.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Sphingolipid biology and its role in cancer development and therapy

2016 Clinical case reports and reviews
Show All
- Source
- Cite
- Save
Citations (0)
Isolated Chemotherapeutic Perfusion as Neoadjuvant Therapy for Advanced/Unresectable Pelvic Malignancy

2016
Show All
- Source
- Cite
- Save
Citations (0)
C6-ceramide's effect on KRAS-defined colorectal cancer cells treated with oxaliplatin, 5-fluoruracil with and without cetuximab.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
C6-ceramide to induce sensitivity to cetuximab (Cet) in KRAS mutant colorectal cancer (CRC).

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Effect of neoadjuvant pelvic perfusion on symptom control and resection of pelvic recurrent rectal cancer.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
C6-ceramide to restore sensitivity to cetuximab in KRAS-mutant colorectal cancer.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)